Peter J. Carman

Peter J. Carman

Auto-generated profile, based on publicly available information

Peter J. Carman

Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2018 in Biophysical Reviews
Verified
Journal Article
Closed access
PDF file
PCPeter J. Carman
Peter J. Carman
RDRoberto Dominguez
Roberto Dominguez

20 May 2021 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
SCSydney E. Cason
Sydney E. Cason
PCPeter J. Carman
Peter J. Carman
CDClaire Van Duyne
Claire Van Duyne
JGJuliet Goldsmith
Juliet Goldsmith
RDRoberto Dominguez
Roberto Dominguez
EHErika L.F. Holzbaur
Erika L.F. Holzbaur
Autophagy is a degradative pathway required to maintain homeostasis. Neuronal autophagosomes form constitutively at the axon terminal and mature via lysosomal fusion during dynein-mediated transport to the soma. How the dynein–autophagosome interaction is regulated is unknown. Here, we identify multiple dynein effectors on autophagosomes as they transit along the axons of primary neurons. In the distal axon, JIP1 initiates autophagosomal transport. Autophagosomes in the mid-axon require HAP1 and Huntingtin. We find that HAP1 is a dynein activator, binding the dynein–dynactin complex via canonical and noncanonical interactions. JIP3 is on most axonal autophagosomes, but specifically regulates the transport of mature autolysosomes. Inhibiting autophagosomal transport disrupts maturation, and inhibiting autophagosomal maturation perturbs the association and function of dynein effectors; thus, maturation and transport are tightly linked. These results reveal a novel maturation-based dynein effector handoff on neuronal autophagosomes that is key to motility, cargo degradation, and the maintenance of axonal health.

23 June 2023 in Science
Verified
Journal Article
Closed access
PCPeter J. Carman
Peter J. Carman
KBKyle R. Barrie
Kyle R. Barrie
GRGrzegorz Rebowski
Grzegorz Rebowski
RDRoberto Dominguez
Roberto Dominguez
The barbed and pointed ends of the actin filament (F-actin) are the sites of growth and shrinkage and the targets of capping proteins that block subunit exchange, including CapZ at the barbed end and tropomodulin at the pointed end. We describe cryo-electron microscopy structures of the free and capped ends of F-actin. Terminal subunits at the free barbed end adopt a “flat” F-actin conformation. CapZ binds with minor changes to the barbed end but with major changes to itself. By contrast, subunits at the free pointed end adopt a “twisted” monomeric actin (G-actin) conformation. Tropomodulin binding forces the second subunit into an F-actin conformation. The structures reveal how the ends differ from the middle in F-actin and how these differences control subunit addition, dissociation, capping, and interactions with end-binding proteins.

1 August 2019 in Cell Reports
Verified
Journal Article
Open access
ATAmber Tariq
Amber Tariq
JLJiaBei Lin
JiaBei Lin
J Meredith Jackrel
Meredith Jackrel
CHChristina D. Hesketh
Christina D. Hesketh
PCPeter J. Carman
Peter J. Carman
JSJames Shorter
James Shorter
Hsp104 is an AAA+ protein disaggregase, which can be potentiated via diverse mutations in its autoregulatory middle domain (MD) to mitigate toxic misfolding of TDP-43, FUS, and α-synuclein implicated in fatal neurodegenerative disorders. Problematically, potentiated MD variants can exhibit off-target toxicity. Here, we mine disaggregase sequence space to safely enhance Hsp104 activity via single mutations in nucleotide-binding domain 1 (NBD1) or NBD2. Like MD variants, NBD variants counter TDP-43, FUS, and α-synuclein toxicity and exhibit elevated ATPase and disaggregase activity. Unlike MD variants, non-toxic NBD1 and NBD2 variants emerge that rescue TDP-43, FUS, and α-synuclein toxicity. Potentiating substitutions alter NBD1 residues that contact ATP, ATP-binding residues, or the MD. Mutating the NBD2 protomer interface can also safely ameliorate Hsp104. Thus, we disambiguate allosteric regulation of Hsp104 by several tunable structural contacts, which can be engineered to spawn enhanced therapeutic disaggregases with minimal off-target toxicity.

1 March 2020 in Current Biology
Verified
Journal Article
Closed access
RKReena Kumari
Reena Kumari
YJYaming Jiu
Yaming Jiu
PCPeter J. Carman
Peter J. Carman
STSari Tojkander
Sari Tojkander
KKKonstantin Kogan
Konstantin Kogan
PLPekka Lappalainen
Pekka Lappalainen

7 December 2020 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
RBRichard Wayne Baker
Richard Wayne Baker
JRJanice M. Reimer
Janice M. Reimer
PCPeter J. Carman
Peter J. Carman
BTBengi Turegun
Bengi Turegun
TATsutomu Arakawa
Tsutomu Arakawa
ALAndres E. Leschziner
Andres E. Leschziner